Journal for ImmunoTherapy of Cancer (Nov 2023)

616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

  • Elizabeth Gibson,
  • Sara Lonardi,
  • Christopher Jackson,
  • Armando Santoro,
  • Jose Manuel Trigo Perez,
  • Iwona Lugowska,
  • R Donald Harvey,
  • Anne O’Donnell,
  • Richard North,
  • Loes Maria Latten-Jansen,
  • Marcelo Garrido Salvo,
  • Matías Chacón,
  • Linghui Li,
  • Devanand Joseph,
  • Bryan Bennett,
  • Balmeet Gurm,
  • Wee-Teck Ng,
  • Aitana Calvo

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0616
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.